Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.
about
Recurrence and Treatment after Renal Transplantation in Children with FSGSCirculating Permeability Factors in Primary Focal Segmental Glomerulosclerosis: A Review of Proposed CandidatesA circulating permeability factor in focal segmental glomerulosclerosis: the hunt continuesPathogenesis of Focal Segmental GlomerulosclerosisPersonalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal DiseasesFluorescence dilution technique for measurement of albumin reflection coefficient in isolated glomeruli.Serum glomerular albumin permeability activity: association with rapid progression to end-stage renal disease in focal segmental glomerulosclerosis.Unwinding focal segmental glomerulosclerosisChanges in podocyte TRPC channels evoked by plasma and sera from patients with recurrent FSGS and by putative glomerular permeability factors.Focal segmental glomerular sclerosis: do not overlook the role of immune response.STAT3 activation in infection and infection-associated cancer.What are we missing in the clinical trials of focal segmental glomerulosclerosis?Multiple Targets for Novel Therapy of FSGS Associated with Circulating Permeability Factor.Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family.Removal of focal segmental glomerulosclerosis (FSGS) factor suPAR using CytoSorb.Investigational drugs in development for focal segmental glomerulosclerosis.Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.
P2860
Q26746985-F2866F97-715C-4978-B2EE-CB75CCC29807Q26747221-A0EED7EA-30EA-463B-A054-6ED744A0311FQ26776389-0F6D4865-AF5B-4923-A0D0-2DA0025000DFQ28067299-AE8A5B07-1437-423D-941B-913F291DB4C3Q33838866-ABDD93DC-7781-401F-8BBF-7F4AB1E3B0F3Q36382099-78D30711-2EE3-4235-BB35-781E671848EBQ36789030-54A0533D-52ED-48E1-B566-03A276891771Q38685434-40DEA9F5-7722-4546-8BAD-19AD642728BAQ38718670-C1BB2EBC-9285-4412-9288-04FB269463E6Q38742004-7A7FA344-19B0-4413-AACC-1338416668EDQ39145689-70085B7C-EAB8-4DEE-9580-109BDD63A4B4Q39229298-B3F7368E-FA7B-4C3C-A455-A50CB96972ADQ41688065-0F208294-2405-4007-8BB3-7E81E870FBE3Q42254379-C90C5CCA-7F25-403D-893E-2996AEE36128Q48333014-A8CD61B0-136A-46DE-A556-E3B4C28DD22EQ51840896-5DD86F28-06C1-4729-A47F-242CB732F0F5Q52715295-1D22598C-80ED-43F2-90BF-075BBE35E80B
P2860
Janus kinase 2/signal transducer and activator of transcription 3 inhibitors attenuate the effect of cardiotrophin-like cytokine factor 1 and human focal segmental glomerulosclerosis serum on glomerular filtration barrier.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@en
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@nl
type
label
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@en
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@nl
prefLabel
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@en
Janus kinase 2/signal transduc ...... glomerular filtration barrier.
@nl
P2093
P2860
P1476
Janus kinase 2/signal transduc ...... glomerular filtration barrier
@en
P2093
Ellen T McCarthy
Jean-François Gauchat
Jianping Zhou
Mukut Sharma
Ram Sharma
Virginia J Savin
P2860
P304
P356
10.1016/J.TRSL.2015.03.002
P577
2015-03-16T00:00:00Z